Policy & Regulation Today - September 5, 2026

This Week at FDA: Foreign clinical trial scrutiny, botanical drugs, and an EUA declaration

NY Judge Won't Block HHS Sharing Of Aid Recipients' Info

FDA Approves Ionis Pharma Drug, the First for Ultra-Rare Alexander Disease

Ionis Pharmaceuticals’ zilganersen, brand name Zanvastro, is the first disease-modifying therapy approved for the neurological disorder Alexander disease. While Ionis has experience developing medicines for rare neuroscience indications, Zanvastro will be the first neurology product the company brings to the market without a commercialization partner. The post FDA Approves Ionis Pharma Drug, …

How Is FDA Regulating AI Medical Devices in 2026?

From Weddings To Iftar: Maharashtra FDA Makes Prior Permission Mandatory For Mass Feasts

Lawmakers to subpoena Oracle execs as EHR project costs rise

After nearly tripling its contract ceiling with the VA, Congress wants to hear from Oracle’s Executive Chairman Larry Ellison and CEO Mike Sicilia about the project’s escalating costs and lengthy timeline.